Patents by Inventor Stein Saeboe-Larssen

Stein Saeboe-Larssen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080187551
    Abstract: The present invention relates to polypeptides, and nucleic acids DNA encoding these polypeptides, capable of eliciting an immune reaction against cancer, methods for generating T lymphocytes capable of recognising and destroying tumour cells, and pharmaceutical compositions for the treatment, prophylaxis or diagnosis of cancer.
    Type: Application
    Filed: March 5, 2008
    Publication date: August 7, 2008
    Applicant: GEM VAX AS
    Inventors: Gustav Gaudernack, Stein Saeboe-Larssen, Mona Moller, Jon Amund Eriksen
  • Publication number: 20060194731
    Abstract: The present invention relates to polypeptides, and nucleic acids DNA encoding these polypeptides, capable of eliciting an immune reaction against cancer, methods for generating T lymphocytes capable of recognising and destroying tumour cells, and pharmaceutical compositions for the treatment, prophylaxis or diagnosis of cancer.
    Type: Application
    Filed: March 29, 2006
    Publication date: August 31, 2006
    Applicant: GemVax As
    Inventors: Gustav Gaudernack, Stein Saeboe-Larssen, Mona Moller, Jon Eriksen
  • Publication number: 20040235175
    Abstract: The present invention relates to a method of inserting RNA into cells. In this method, cells are transfected with RNA using electroporation in order to achieve high transfection efficiency. The method is useful, inter alia, in providing cells to be used in cell-based therapies, e.g. in preparing cells useful as anti-cancer vaccines. Preferably, the RNA has a 5′ cap and a 3′ poly (A) tail.
    Type: Application
    Filed: November 4, 2003
    Publication date: November 25, 2004
    Inventors: Gustav Gaudernack, Stein Saeboe-Larssen
  • Publication number: 20040072759
    Abstract: The present invention relates to polypeptides, and nucleic acids DNA encoding these polypeptides, capable of eliciting an immune reaction against cancer, methods for generating T lymphocytes capable of recognising and destroying tumour cells, and pharmaceutical compositions for the treatment, prophylaxis or diagnosis of cancer.
    Type: Application
    Filed: June 19, 2003
    Publication date: April 15, 2004
    Inventors: Gustav Gaudernack, Stein Saeboe-Larssen, Mona Moller, Jon Amund Eriksen